Merck reports positive results from pivotal phase 3 trials of once-daily, oral, two-drug, single ...
|
In the US, doravirine is approved for the treatment of
adults with HIV-1 in combination with other antiretrovirals, as a
single agent (Pifeltro) and a ... |